The improvement of stroke outcome at day 7 after daily treatment with ENBA was concomitant with the significant decrease of TSPO expression with [18F]DPA-714, supporting the role played by A1ARs on neuroinflammation after cerebral ischemia (Figure 6G). The gene discussed is TSPO; the disease is brain ischemia.